Compare GODAVARI DRU with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GODAVARI DRU PANACEA BIOTECH GODAVARI DRU/
PANACEA BIOTECH
 
P/E (TTM) x 9.5 -6.3 - View Chart
P/BV x 1.9 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GODAVARI DRU   PANACEA BIOTECH
EQUITY SHARE DATA
    GODAVARI DRU
Mar-21
PANACEA BIOTECH
Mar-21
GODAVARI DRU/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs60265 22.6%   
Low Rs10110 8.7%   
Sales per share (Unadj.) Rs162.9102.0 159.7%  
Earnings per share (Unadj.) Rs5.5-24.1 -22.7%  
Cash flow per share (Unadj.) Rs7.1-16.6 -42.8%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs32.4-37.3 -86.7%  
Shares outstanding (eoy) m7.5361.25 12.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.21.8 11.6%   
Avg P/E ratio x6.3-7.8 -81.4%  
P/CF ratio (eoy) x4.9-11.3 -43.2%  
Price / Book Value ratio x1.1-5.0 -21.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m26211,498 2.3%   
No. of employees `000NANA-   
Total wages/salary Rs m391,563 2.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m1,2276,248 19.6%  
Other income Rs m4106 3.9%   
Total revenues Rs m1,2316,354 19.4%   
Gross profit Rs m98757 13.0%  
Depreciation Rs m12461 2.7%   
Interest Rs m331,853 1.8%   
Profit before tax Rs m57-1,451 -3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1626 60.0%   
Profit after tax Rs m41-1,477 -2.8%  
Gross profit margin %8.012.1 66.2%  
Effective tax rate %27.7-1.8 -1,527.3%   
Net profit margin %3.4-23.6 -14.2%  
BALANCE SHEET DATA
Current assets Rs m6765,110 13.2%   
Current liabilities Rs m5055,959 8.5%   
Net working cap to sales %13.9-13.6 -102.6%  
Current ratio x1.30.9 156.1%  
Inventory Days Days1114 0.9%  
Debtors Days Days134,256,17749 271,384,190.0%  
Net fixed assets Rs m2358,379 2.8%   
Share capital Rs m7561 123.0%   
"Free" reserves Rs m169-2,348 -7.2%   
Net worth Rs m244-2,287 -10.7%   
Long term debt Rs m1457,351 2.0%   
Total assets Rs m91113,489 6.8%  
Interest coverage x2.70.2 1,252.3%   
Debt to equity ratio x0.6-3.2 -18.5%  
Sales to assets ratio x1.30.5 290.6%   
Return on assets %8.22.8 293.2%  
Return on equity %16.964.6 26.2%  
Return on capital %23.27.9 292.3%  
Exports to sales %1.034.8 2.9%   
Imports to sales %62.19.0 693.0%   
Exports (fob) Rs m122,176 0.6%   
Imports (cif) Rs m761560 136.0%   
Fx inflow Rs m122,270 0.5%   
Fx outflow Rs m761657 116.0%   
Net fx Rs m-7491,613 -46.4%   
CASH FLOW
From Operations Rs m131,068 1.2%  
From Investments Rs m-13-477 2.6%  
From Financial Activity Rs m1-471 -0.3%  
Net Cashflow Rs m2119 1.8%  

Share Holding

Indian Promoters % 56.1 73.6 76.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.5 0.1 384.6%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 43.9 26.4 166.1%  
Shareholders   5,750 52,465 11.0%  
Pledged promoter(s) holding % 5.2 94.3 5.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GODAVARI DRU With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GODAVARI DRU SHARE PRICE


Jan 25, 2022 (Close)

TRACK GODAVARI DRU

  • Track your investment in GODAVARI DRU with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GODAVARI DRU - IND. SWIFT COMPARISON

COMPARE GODAVARI DRU WITH

MARKET STATS